Mosaic ImmunoEngineering Inc. financial data

Symbol
CPMV on OTC
Location
Huntington Beach, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.5% % -0.64%
Debt-to-equity -101% % -0.01%
Return On Equity 9.5% % -44%
Return On Assets -763% % 44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,242,137 shares
Common Stock, Shares, Outstanding 7,242,137 shares 0%
Entity Public Float $466,000 USD -43%
Common Stock, Value, Issued $72 USD 0%
Weighted Average Number of Shares Outstanding, Basic 7,236,447 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 7,236,447 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $64,098 USD -71%
General and Administrative Expense $554,045 USD -30%
Operating Income (Loss) $618,143 USD 38%
Nonoperating Income (Expense) $48,810 USD 18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $666,953 USD 37%
Income Tax Expense (Benefit) $4,800 USD
Net Income (Loss) Attributable to Parent $671,753 USD 37%
Earnings Per Share, Basic 0 USD/shares 36%
Earnings Per Share, Diluted 0 USD/shares 36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $31,761 USD 454%
Assets, Current $55,298 USD 38%
Assets $55,298 USD 38%
Accounts Payable, Current $133,759 USD -6.9%
Employee-related Liabilities, Current $4,135,109 USD 14%
Accrued Liabilities, Current $658,047 USD 0.66%
Liabilities, Current $5,914,818 USD 12%
Liabilities $7,362,181 USD 10%
Retained Earnings (Accumulated Deficit) $9,357,029 USD -7.7%
Stockholders' Equity Attributable to Parent $7,306,883 USD -10%
Liabilities and Equity $55,298 USD 38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $29,089 USD 68%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 7,242,137 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,761 USD 454%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $3,504,861 USD 11%
Deferred Tax Assets, Operating Loss Carryforwards $685,824 USD 55%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $2,050,073 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%